Suppr超能文献

小鼠肾脏中汞化合物的肾小管分泌与重吸收

Tubular secretion and reabsorption of mercury compounds in mouse kidney.

作者信息

Tanaka-Kagawa T, Naganuma A, Imura N

机构信息

Department of Public Health, School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.

出版信息

J Pharmacol Exp Ther. 1993 Feb;264(2):776-82.

PMID:8094752
Abstract

To determine whether Hg accumulated in renal cells is secreted into the lumen of proximal tubules with intracellular glutathione (GSH) and reabsorbed by tubular cells via a gamma-glutamyltranspeptidase (gamma-GTP)-dependent process as in the case of GSH itself, the effect of postadministration of acivicin (1 mmol/kg i.p.), a gamma-GTP inhibitor, on renal Hg accumulation was investigated in mice. Renal Hg content 4 hr after injection of CH3HgCl or HgCl2 (5 mumol/kg i.v.) was decreased to 35 or 44% of control, respectively, but urinary Hg excretion was increased by acivicin administration 2 hr after injection of the mercurials. When renal GSH was decreased to 19% of control by treatment with DL-buthionine-S,R-sulfoximine (4 mmol/kg s.c.) 2 hr before acivicin injection, the increase in urinary Hg excretion caused by acivicin was suppressed. Acivicin administration 24 hr after injection of the mercurials decreased renal methylmercury content determined 2 hr after acivicin injection and increased urinary Hg excretion. The postadministration of acivicin, however, did not affect the renal content of inorganic Hg which predominantly bound to metallothionein (MT) induced by HgCl2 itself. Pretreatment with Bi(NO3)3 as a renal MT inducer diminished the effect of acivicin administered 2 hr after HgCl2 injection on renal Hg content and urinary excretion. These results suggest that methylmercury and inorganic Hg bound to ligands other than MT in renal cytosol may be secreted into the lumen of proximal tubules with intracellular GSH and be reabsorbed via a gamma-GTP-dependent process.

摘要

为了确定肾脏细胞中积累的汞是否会与细胞内谷胱甘肽(GSH)一起分泌到近端小管腔中,并像GSH自身那样通过γ-谷氨酰转肽酶(γ-GTP)依赖性过程被肾小管细胞重吸收,研究了γ-GTP抑制剂阿西维辛(1 mmol/kg腹腔注射)给药后对小鼠肾脏汞积累的影响。注射氯化甲基汞或氯化汞(5 μmol/kg静脉注射)4小时后,肾脏汞含量分别降至对照的35%或44%,但在注射汞剂2小时后给予阿西维辛会增加尿汞排泄。在阿西维辛注射前2小时用DL-丁硫氨酸-S,R-亚砜亚胺(4 mmol/kg皮下注射)处理使肾脏GSH降至对照的19%时,阿西维辛引起的尿汞排泄增加受到抑制。在注射汞剂24小时后给予阿西维辛,会降低阿西维辛注射2小时后测定的肾脏甲基汞含量,并增加尿汞排泄。然而,阿西维辛给药后并不影响主要与氯化汞自身诱导的金属硫蛋白(MT)结合的无机汞的肾脏含量。用硝酸铋作为肾脏MT诱导剂进行预处理,可减弱氯化汞注射2小时后给予的阿西维辛对肾脏汞含量和尿排泄的影响。这些结果表明,肾脏细胞溶质中与MT以外的配体结合的甲基汞和无机汞可能会与细胞内GSH一起分泌到近端小管腔中,并通过γ-GTP依赖性过程被重吸收。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验